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Abstract
Aim: “To evaluate oncological and surgical outcomes of different levels of tumor thrombus and tumor characteristics secondary to renal cell 
carcinoma (RCC)”.
Materials and Methods: Retrospective review from 2013 to 2020 of 34 patients who underwent radical nephrectomy with thrombectomy for 
RCC with tumor thrombus extending into the inferior vena cava (IVC) and right atrium (RA) at our center. Level I and most level II tumors 
were removed using straight forward occluding maneuvers with control of the contralateral renal vein. None of the patients had level III tumor 
extensions in our study group. For level IV thrombus, a beating heart surgery using a simplified cardiopulmonary bypass (CPB) technique was 
used for retrieval of thrombus from the right atrium.
Results: “Of the 34 patients with thrombus”, 19 patients had level I, 12 patients had level II, none had level III, and three patients had level IV 
thrombus. Two patients required simplified CPB. Another patient with level IV thrombus CPB, was not attempted in view of refractory hypoten-
sion intraoperatively. Pathological evaluation showed clear-cell carcinoma in 67.64%, papillary carcinoma in 17.64%, chromophobe in 5.8%, and 
squamous cell carcinoma in 8.8% of cases. Left side thrombectomy was difficult surgically, whereas right side thrombectomy did not have any sur-
vival advantage. Mean blood loss during the procedure was 325 mL, ranging from 200 to 1000 mL, and mean operative time was 185 min, ranging 
from 215 to 345 min. The immediate postoperative mortality was 2.9%. Level I thrombus had better survival compared to level II thrombus.
Conclusion: Radical nephrectomy with tumor thrombectomy remains the mainstay of treatment in RCC with inferior venacaval extension. The 
surgical approach and outcome depends on primary tumor size, location, level of thrombus, local invasion of IVC, any hepato-renal dysfunction 
or any associated comorbidities. The higher the level of thrombus, the greater is the need for prior optimization and the adoption of a multidis-
ciplinary approach for a successful surgical outcome.
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atrium (RA) were enrolled. These patients had been admit-
ted and operated upon at our center, the Sher-i-Kashmir 
Institute of  Medical Sciences (SKIMS), from January 
2013 to  January 2020. Patients who had received neoadju-
vant targeted therapy were excluded from the study. In all 
patients,  Contrast-Enhanced Computed Topography/Mag-
netic  Resonance imaging (CECT/MRI) was performed to 
assess the cephalic extension of the thrombus. Chest X-ray 
and bone scans were performed preoperatively in all patients 
to exclude metastasis. The level of renocaval thrombus was 
staged as follows: level I: adjacent to the ostium of the renal 
vein; level II: extending up to the lower aspect of the liver; 
level III: involving the intrahepatic portion of the IVC but 
below the diaphragm; and level IV: extending above the dia-
phragm. Based on surgeon preference and the level of throm-
bus, the surgical approach was selected. Level 1 and most 
level II thrombi were removed using straight forward occlud-
ing maneuvers with control of the contralateral renal vein for 
right-sided tumors and control of right renal artery for left-
sided tumors. For level IV thrombi, a beating heart surgery 
with a simplified cardiopulmonary bypass (CPB) technique 
was used for the retrieval of the thrombus from RA.
Operative Technique for Different  
Levels of Thrombus
The surgical technique used for different levels of thrombus 
extension in our study is as follows. For level I (Figure  1) 
thrombus, vascular side clamps are used without occluding 
IVC inflow. The cavotomy defect is then sewn using a contin-
uous prolene 4-0 suture. Level II thrombus  (Figure 2A and B) 
often necessitates more extensive mobilization of the IVC. 
Introduction
Renal cell carcinoma (RCC) is responsible for 2–3% of all 
adult malignancies and is one of the fatal tumors of the renal 
system. RCC consists of various subtypes associated with 
different parts of the nephron, each with specific genetic 
and tumor biology (1). A striking and significant feature of 
RCC lies in its tendency to grow intraluminally into the renal 
venous system in a cranial direction known as venous tumor 
thrombosis. The growth may extend till the right atrium 
(RA) or beyond. This growth of RCC into the renal venous 
system has been observed among 4–10% of the patients. 
With frequent use of ultrasonography, the diagnosis of 
RCC with venous involvement has steadily increased even in 
asymptomatic cases (2). Fortunately, 45–70% of the patients 
with venous tumor thrombosis can be successfully treated by 
nephrectomy combined with thrombectomy. Among patients 
with a primary diagnosis of renal mass, the presence of lower 
extremity edema, dilated superficial abdominal veins, pro-
teinuria, pulmonary embolism, isolated right-sided varico-
cele, and right atrial mass raises the suspicion of renocaval 
tumor extension. “Surgery becomes more complex; the more 
the extension of the thrombus, the higher the morbidity and 
mortality”. A multidisciplinary approach is required for the 
management of these patients, and it is a challenging sce-
nario for the uro-oncologist.
Materials and Methods
It was a retrospective study in which all patients with a 
diagnosis of renal cell carcinoma (RCC) with tumor throm-
bus extension into the inferior vena cava (IVC) and right 
Figure 1: Level 1 thrombus (HPE Squamous cell carcinoma) with arrows showing  level 1 thrombus.
RCC with tumor thrombus
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using digital manipulation to ensure complete removal from 
retrohepatic IVC. Intermittent suctioning is performed using 
a pump sucker as hepatic veins are opened up. Cavotomy is 
closed using 4-0 prolene suture. After completely de-airing 
the RA, the atriotomy is also closed. Patient is gradually 
Proximal and distal control of IVC is necessary with ligation 
and division of lumbar veins to prevent significant blood 
loss. For the retrieval of thrombus, vascular clamps are used 
with clamping of the left renal vein in case of right-sided 
renal tumors and clamping of the right renal artery in case 
of left-sided renal tumors. The cavotomy defect is sewn 
using continuous prolene 4-0 suture. For level IV thrombi 
 (Figure 3), a beating heart surgery with a simplified CPB 
technique was used for retrieval of thrombus from RA. For 
level IV thrombi, ligation of renal artery is followed by rad-
ical nephrectomy using chevron incision. The left renal vein 
is looped, and IVC below the renal vein is skeletonized for 
a length of about 5 cm to prepare it for IVC cannulation. 
A purse string is made on it using 4-0 prolene monofilament 
suture and the subhepatic portion of IVC is dissected. Then, 
median sternotomy is performed and pericardium is opened. 
Aortic purse-string suture with 3-0 prolene is taken on the 
ascending aorta. The intrapericardial portion of the supe-
rior vena cava (SVC) is looped, and a purse-string with 3-0 
prolene is taken. Patient is heparinized with 300 Units/kg 
body weight of heparin. Aortic and venous cannulations are 
performed, and patient is put on complete CPB after both 
SVC and IVC are snugged with Rummel tourniquet. No 
vent cannula is put in. Patient is cooled to 35°C. On beating 
heart under normothermic CPB, RA thrombus (Figure 4) is 
extracted without cross-clamping the aorta. Right atriotomy 
is performed and tumor thrombus, which is organized and 
firm, is carefully retrieved. IVC is snugged at its junction with 
RA to prevent spillover from IVC into RA. Subhepatic IVC is 
incised longitudinally, and the tumor thrombus is extracted, 
Figure 3: Level 4 thrombus  with arrow (Black) showing mass 
in right kidney and white arrow thrombus in IVC extending 
to right atrium.
Figure 2: (A) Level 2 thrombus with proximal, distal and left renal tourniquet. (B) Completion of tumor thrombectomy with 
renal mass (arrow) in situ.
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weaned off  the bypass. “Patients were followed up quarterly 
in the first year, semiannually in the second year, and annu-
ally thereafter”.
Results
A total of 34 patients who had been diagnosed with RCC 
with venous tumor extension over a period of 7 years were 
enrolled in this study. All these patients underwent radical 
nephrectomy with thrombectomy at our center as per the 
surgical techniques detailed above, depending on the level of 
tumor extension. The mean age of the study group was 66 ± 
8 years, with the youngest patient being 17 years old and the 
oldest being 71 years old. The group included 24 male and 10 
female patients with a male:female ratio of 2.4:1. Of the 34 
patients, 27 patients (79.42%) had right kidney tumor while 
seven patients (20.58%) had left kidney involvement. Among 
the 34 patients, 19 (55.9%) had level I thrombus, 12 (35.3%) 
had level II thrombus, and three (8.8%) had level IV tumor 
thrombus extension. None of the patients in our study group 
had level III tumor extension.
Of the 34 patients, 28 patients had no intraoperative and 
major postoperative complications. The details of remain-
ing 6 patients are shown in Table 1. Mean blood loss during 
the procedure was 325 mL, ranging from 200 to 1000 mL, 
and mean operative time was 185 min, ranging from 215 to 
345 min. One patient (2.9%) with level IV thrombus died 
immediately after surgery. Histopathological examination 
revealed clear-cell carcinoma in 23 cases (67.64%), papil-
lary carcinoma in six cases (17.64%), chromophobe in two 
cases (5.8%), and squamous cell carcinoma in 3 cases (8.8%). 
Figure 4: Opening of right atrium with arrow showing 
thrombus in situ.
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Mean follow-up of patients in our study group was 7 years 
± 3 months. “Level I thrombus patients had better survival 
when compared to level II thrombus patients”.
Discussion
Approximately, 2–16% of RCC patients had extension of 
tumor thrombus to RA (4–6). In the 2010 International 
Union against Cancer TNM staging system, the diameter of 
renal tumors and the level of tumor thrombus are import-
ant prognostic indicators. This surgical procedure has two 
components for the excision of renal mass and IVC tumor 
thrombus. In our series, majority of patients had level I 
thrombus (55.88%), and histopathological examination of 
resected specimens (19 nos.) revealed squamous cell carci-
noma in 03 cases (15.78%), clear-cell carcinoma in ten cases 
(52.63%), papillary carcinoma in 04 cases (21.05%), and 
chromophobe cell carcinoma in 02 case (10.52%). In this 
cohort of level I thrombus, 16 patients were alive till last fol-
low-up until 5 years with no recurrence of tumor thrombus 
or distant metastasis. Three patients with histopathological 
examination HPE of squamous cell carcinoma died within 
2 years of surgery and one patient developed lung metasta-
sis. Of the 12 patients (35.29%) with level II thrombus, 10 
(83.34%) had clear-cell carcinoma and two (16.66%) had 
papillary carcinoma. In the level IV thrombus group (8.8%), 
histopathological examination revealed clear cell carcinoma 
with sarcomatoid variant in all three cases and only two 
RCC with tumor thrombus
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if  tumor thrombus has extended to RA or RV across the tri-
cuspid valve. Arrested heart has a definite advantage in this 
regard. Risk of paradoxical air or tumor embolism via Atrial 
septal defect/Patent foramen ovale (ASD or PFO) to brain, 
coronaries, or other organs can have catastrophic results; 
however, the chances for such adverse events are minimal 
given the on-table maneuvers like head down, and the avoid-
ance of the emptying of left atrium.
Blood loss is minimal in circulatory arrest due to the 
standstill circulatory system at profound hypothermia. But 
in the beating heart technique, the blood loss, which hap-
pens due to hepatic venous and lumbar venous return, is 
collected using a pump sucker via the inferior cavotomy and 
returned back to pump recirculation, and this is what we 
did in two cases and blood loss was minimal. In occasional 
cases, where the cavotomy blood loss may overwhelm the 
pump suction capacity, a brief  Pringle maneuver, at the cost 
of some hepatic ischemia, can be employed to stop hepatic 
venous return till the thrombus is retrieved and the cavot-
omy is closed. However, we did not required to adopt this 
maneuver in both the cases. Predominant advantages of this 
approach include shorter bypass time and operative time, as 
no time was required for rewarming, more physiological for 
myocardium due to continuous coronary perfusion, blood-
less field, except for bleeding from hepatic veins which was 
taken care of by pump suckers, less coagulopathy and post-
operative bleeding. The morbidity related to hypothermic 
circulatory arrest and aortic cross-clamping was avoided. 
Thus, our approach was easy to set up, safe, and simple to 
use. It is ideal to have intraoperative Transesophageal echo-
cardiography (TEE), a noninvasive technique, which is very 
helpful in confirming the exact position of the thrombus 
within IVC and RA, and ensures complete thrombectomy 
were completely resected. In one case only biopsy was taken 
in view of intraoperative hemodynamic instability. All the 
resected specimens had a negative margin. One patient with 
left RCC developed solitary lung metastasis during-follow 
up and was put on tyrosine kinase inhibitors (TKIs) by the 
medical oncologist. The patient behaved well but was lost to 
follow-up after 3 years. The more the length of the tumor 
thrombus, the more challenging it is, necessitating a multi-
disciplinary approach that increases the complexity of the 
management. “Radical resection is the only curative option 
for RCC with a tumor thrombus in the inferior vena cava, 
and accurate pre operative imaging is crucial for a positive 
surgical outcome”. Most patients with IVC extension can be 
treated with nephrectomy with IVC thrombectomy without 
putting the patient on CPB; however, in cases of RA exten-
sion (level IV), CPB is strongly recommended (5). Digital 
manipulation of tumor thrombus to push it from RA into 
IVC without CPB can cause life-threatening blood loss. CPB 
offers a bloodless field and hemodynamic stability during 
thrombectomy from IVC and RA (2, 7–9). There are, how-
ever, inherent complications associated with CPB, including 
increase in operative time, myocardial ischemia during cross-
clamp, arrhythmias, respiratory complications, and postop-
erative hemorrhagic drainage due to onset of coagulopathies 
(5, 10). In literature, some surgeons have used profound 
hypothermia with circulatory arrest to retrieve the tumor 
thrombus from RA (11, 12). The predominant limitations of 
this technique are its associated morbidities, including neu-
rologic complications (delirium, psychosis, and stroke) (13, 
14), thrombocytopenia, and platelet dysfunction, resulting in 
significant bleeding, prolonged and/or improper rewarming 
with postoperative hypothermia, and overall higher mortal-
ity (13, 15). Our approach in level IV thrombus (Figure 5) 
was beating heart on simplified CPB without cross-clamp 
on aorta. Beating heart is more physiological, as the heart 
is allowed to beat normally, maintaining a normal coronary 
perfusion and contractility, while offloading the heart of 
blood volume. As a result, this allows for smooth resumption 
of heart off  bypass. Weaning off  from CPB is quick, smooth, 
and easy, without having to wait for the mandatory period to 
replenish the myocardium with energy substrates needed in 
the case of an arrested heart. This reduces the operative time, 
and facilitates better hemodynamic stability, early extuba-
tion, and early shifting from intensive care unit to the general 
ward. As a result of shorter CPB time, the inherent risks of 
extracorporeal circulation are minimized, although not elim-
inated. These include less systemic inflammatory response, 
less coagulopathy and thrombocytopenia, thereby less post-
operative bleeding and blood transfusions; less chances of 
embolism, stroke, and post-CPB psychosis.
The disadvantages of this approach include: chances of 
intraoperative bleeding from cavotomy or arteriotomy are 
higher in beating heart, and it negatively impacts visibility, 
Figure 5: Completion of nephrectomy with tumor thrombus 
level 4 with  arrow showing thrombus removed from atrium 
and IVC.
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(16, 17). In our series, a total of three patients with level IV 
thrombus were included. Two patients had a smooth intra-
operative course and the final biopsy revealed a clear-cell 
carcinoma with a sarcomatoid variant. Both the patients 
were disease-free for first 2 years of follow-up; one patient 
died in another hospital due to acute myocardial infarction, 
while another patient developed recurrence at the adrenal 
region and was put on TKIs (sunitinib) by medical oncol-
ogy and subsequently died after detection of recurrence at 6 
months. One patient with level IV thrombus had intraoper-
ative hemodynamic instability on opening the abdomen, as 
significant amount of ascitic fluid (approximately 2 L) was 
drained, to achieve early control of the right renal artery. All 
pressor supports were tried; however, on the operating table, 
the patient had refractory hypotension, and the cardiac sur-
geon refused to put the patient on cardiopulmonary bypass 
because of persistent hypotension. Only renal biopsy was 
performed. Patient was intubated to surgical intensive care 
unit (SICU) for further management. As patient had pre-
operatively hepatic dysfunction because of hepatic conges-
tion but her International normalized ratio (INR) was 1.4, 
with raised creatinine 1.9  mg  dL. Patient developed azote-
mia (acute kidney injury) in the SICU and was put on dial-
ysis by the nephrology team, but the patient continued to be 
sick and ultimately died in the SICU without undergoing 
nephrectomy and thrombectomy. Retrospectively, the fatality 
could be the result of the sudden withdrawal of the ascitic 
fluid without any cover of albumin, or the rapid reduction 
of atrial pressure, or the vasodilation in splanchnic bed with 
reduced venous return to the heart as IVC was completely 
occluded by tumor thrombus. Another explanation was the 
poorly developed collaterals. The entire multidisciplinary 
team believed that the patient’s refractory hypotension was 
the result of aggressive removal of ascitic fluid and poorly 
developed collaterals. To avoid this hemodynamic instabil-
ity on the operating table, we believe that such patients need 
serial paracentesis before surgery under albumin coverage. 
Such a complication has not been reported in literature, and 
further study for such initial intraoperative hemodynamic 
instability is necessary. We believe that the clinical and oper-
ative characteristics of different levels of reno-caval tumor 
thrombus have a significant impact on the surgical outcome. 
We have not used any neoadjuvant systemic therapy in any 
of our cases. The rationale for not using targeted therapy 
before surgery as upfront surgical resection remains the cor-
nerstone of any RCC. Preoperatively targeted therapy with 
TKIs is hypothesized to facilitate resectability, reduce sur-
gical morbidity, and allow for nephron-sparing surgery. In 
our case series, none of the patients had bilateral tumors or 
tumor in a solitary kidney with IVC tumor thrombus. More-
over, the duration and timing of TKI is varied among the 
previous reports, and the associated toxicity and cost of the 
treatment is an impediment in its use in level IV thrombus.
Conclusion
Radical nephrectomy with tumor thrombectomy remains 
the mainstay of treatment in RCC with IVC extension. The 
surgical approach and outcome depends on primary tumor 
size, location, level of thrombus, local invasion of IVC, any 
hepatorenal dysfunction, or other associated comorbid con-
ditions. The higher the level of the thrombus, the more is the 
need for prior optimization and a multidisciplinary approach 
for a successful surgical outcome.
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